Phthalazinones

US7875614B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Hans-Peter Buchstaller · Griesheim, DE
• Dirk Finsinger · Darmstadt, DE
• Kai Schiemann · Darmstadt, DE
• Ulrich Emde · Darmstadt, DE
• Frank Zenke · Darmstadt, DE
• Christiane Amendt · Mühltal, DE

Key dates

• Filing date: Feb 21, 2006
• Grant date: Jan 25, 2011
• Expiry date: Jan 11, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula I, in which R, R1, R2, R3, R4, R5, R6, R7, R8, Z1, Z2, Z3 and Y1 have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours